Article
Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment.
Scientific reports - 31 Jan 2022
Kim Hyung-Don, Kim Sun Young, Kim Jihun, Kim Jeong Eun, Hong Yong Sang, Han Buhm, Tak Eunyoung, Ryu Yeon-Mi, Kim Sang-Yeob, Kim Tae Won
Abstract excerpt
We aimed to investigate the dynamic changes of gene expression profiles and immune microenvironment linked to resistance to cetuximab-based treatments in patients with metastatic colorectal cancer (mCRC). A total of 106 patients with RAS-wild type mCRC who were treated with cetuximab-based treatments were included as the study population. RNA-sequencing and multiplexed immunohistochemistry were performed using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
